The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
14-3-3 proteins—an update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,602
Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., & McKeon, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80275-0 · Cited by 2,085
The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity
Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H., Gamblin, S. J., Smerdon, S. J., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)80487-0 · Cited by 1,604
14-3-3 Proteins: Structure, Function, and Regulation
Fu, H., Subramanian, R. R., & Masters, S. C. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.617 · Cited by 1,579
Regulation of the G2/M transition by p53
Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,559
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine
Muslin, A. J., Tanner, J. W., Allen, P. M., & Shaw, A. S. (1996) · Cell · doi:10.1016/s0092-8674(00)81067-3 · Cited by 1,381
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142
Regulation of p53 in response to DNA damage
Lakin, N. D., & Jackson, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203015 · Cited by 987
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Regulation of the Cdk inhibitor p27 and its deregulation in cancer
Slingerland, J., & Pagano, M. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<10::aid-jcp2>3.0.co;2-i · Cited by 695
How do 14‐3‐3 proteins work? – Gatekeeper phosphorylation and the molecular anvil hypothesis
Yaffe, M. B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03288-4 · Cited by 660
Logsdon, C. D., Simeone, D. M., Binkley, C. E., Arumugam, T., Greenson, J. K., Giordano, T. J., Misek, D. E., Kuick, R. D., & Hanash, S. (2003) · PubMed · Cited by 596
A unified view of the DNA-damage checkpoint
Melo, J., & Toczyski, D. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00312-5 · Cited by 457
Jin, J., Smith, F. D., Stark, C., Wells, C. D., Fawcett, J. P., Kulkarni, S., Metalnikov, P., O'Donnell, P., Taylor, P., Taylor, L., et al. (2004) · Current Biology · doi:10.1016/j.cub.2004.07.051 · Cited by 448
High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100566997 · Cited by 444
RUBIO, M. P., GERAGHTY, K. M., WONG, B. H. C., WOOD, N. T., CAMPBELL, D. G., MORRICE, N., & MACKINTOSH, C. (2004) · Biochemical Journal · doi:10.1042/bj20031797 · Cited by 442
Hermeking, H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1230 · Cited by 437
Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor
Kato, Y., Tapping, R. I., Huang, S., Watson, M. H., Ulevitch, R. J., & Lee, J.-D. (1998) · Nature · doi:10.1038/27234 · Cited by 436
Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zöchbauer‐Müller, S., Farinas, A. J., Vakar‐Lopez, F., Minna, J. D., Sagalowsky, A. I., et al. (2001) · PubMed · Cited by 422
Ras Activation of the Raf Kinase: Tyrosine Kinase Recruitment of the MAP Kinase Cascade
Avruch, J. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.127 · Cited by 391
Chromatographic and Electrophoretic Fractionation of Soluble Proteins of Brain and Liver
Moore, B. W., & McGregor, D. (1965) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)97483-1 · Cited by 379
G2 checkpoint abrogators as anticancer drugs
Kawabe, T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.513.3.4 · Cited by 377
Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization
Fujita, N., Sato, S., Katayama, K., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203668200 · Cited by 358
Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth
Urano, T., Saito, T., Tsukui, T., Fujita, M., Hosoi, T., Muramatsu, M., Ouchi, Y., & Inoue, S. (2002) · Nature · doi:10.1038/nature00826 · Cited by 357
14-3-3 Interacts Directly with and Negatively Regulates Pro-apoptotic Bax
Nomura, M., Shimizu, S., Sugiyama, T., Narita, M., Ito, T., Matsuda, H., & Tsujimoto, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207880200 · Cited by 345
BAD Ser-155 Phosphorylation Regulates BAD/Bcl-XL Interaction and Cell Survival
Tan, Y., Demeter, M. R., Ruan, H., & Comb, M. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004199200 · Cited by 309
Positive Regulation of Wee1 by Chk1 and 14-3-3 Proteins
Lee, J., Kumagai, A., & Dunphy, W. G. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.3.551 · Cited by 291
Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer
Umbricht, C. B., Evron, E., Gabrielson, E., Ferguson, A. T., Marks, J., & Sukumar, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204438 · Cited by 291
Dumaz, N., & Marais, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300182200 · Cited by 252
Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains
Rodriguez, M., Yu, X., Chen, J., & Songyang, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300407200 · Cited by 234
A Structural Basis for 14-3-3σ Functional Specificity*♦
Wilker, E. W., Grant, R. A., Artim, S. C., & Yaffe, M. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500982200 · Cited by 232
Iwata, N., Yamamoto, H., Sasaki, S., Itoh, F., Suzuki, H., Kikuchi, T., Kaneto, H., Iku, S., Ozeki, I., Karino, Y., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203898 · Cited by 229
Organization and evolution of multifunctional Ca2+/CaM-dependent protein kinase genes
Tombes, R. M., Faison, M. O., & Turbeville, J. M. (2003) · Gene · doi:10.1016/j.gene.2003.08.023 · Cited by 226
Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells
Cheng, J. C., Weisenberger, D. J., Gonzales, F. A., Liang, G., Xu, G.-L., Hu, Y.-G., Marquez, V. E., & Jones, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1270-1278.2004 · Cited by 222
Suzuki, H., Itoh, F., Toyota, M., Kikuchi, T., Kakiuchi, H., & Imai, K. (2000) · PubMed · Cited by 218
14‐3‐3 suppresses the nuclear localization of threonine 157‐phosphorylated p27Kip1
Sekimoto, T., Fukumoto, M., & Yoneda, Y. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600198 · Cited by 194
DNA methylation and cancer therapy: new developments and expectations
Esteller, M. (2005) · Current Opinion in Oncology · doi:10.1097/01.cco.0000147383.04709.10 · Cited by 183
Targeted Proteomic Analysis of 14-3-3ς, a p53 Effector Commonly Silenced in Cancer
Benzinger, A., Muster, N., Koch, H. B., Yates, J. R., & Hermeking, H. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500021-mcp200 · Cited by 181
The G2/M Regulator 14-3-3ς Prevents Apoptosis through Sequestration of Bax
Samuel, T., Weber, H. O., Rauch, P., Verdoodt, B., Eppel, J.-T., McShea, A., Hermeking, H., & Funk, J. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106427200 · Cited by 179
Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
Vercoutter‐Edouart, A., Lemoine, J., Bourhis, X. L., Hornez, L., Boilly, B., Nurcombe, V., Révillion-Carette, F., Peyrat, J., & Hondermarck, H. (2001) · PubMed · Cited by 177
Isoform‐specific expression of 14‐3‐3 proteins in human lung cancer tissues
Qi, W., Liu, X., Qiao, D., & Martinez, J. D. (2005) · International Journal of Cancer · doi:10.1002/ijc.20492 · Cited by 175
Integrin-mediated signal transduction pathways.
Cary, L. A., Han, D. C., & Guan, J. (1999) · PubMed · doi:10.14670/hh-14.1001 · Cited by 163
New developments in the neurobiology of the tuberous sclerosis complex
Crino, P. B., & Henske, E. P. (1999) · Neurology · doi:10.1212/wnl.53.7.1384 · Cited by 162
Big Mitogen-activated Kinase Regulates Multiple Members of the MEF2 Protein Family
Kato, Y., Zhao, M. F., Morikawa, A., Sugiyama, T., Chakravortty, D., Koide, N., Yoshida, T., Tapping, R. I., Yang, Y. C., Yokochi, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001573200 · Cited by 154
Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers
Osada, H., Tatematsu, Y., Yatabe, Y., Nakagawa, T., Konishi, H., Harano, T., Tezel, E., Takada, M., & Takahashi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205303 · Cited by 146
Cdc25B activity is regulated by 14-3-3
Forrest, A. R. R., & Gabrielli, B. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204574 · Cited by 129
Honda, H., Nakamoto, T., Sakai, R., & Hirai, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1162 · Cited by 126
Regulation of TSC2 by 14-3-3 Binding
Li, Y., Inoki, K., Yeung, R. S. W., & Guan, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200510200 · Cited by 123
The Clinical Application of Targeting Cancer through Histone Acetylation and Hypomethylation
Gilbert, J., Gore, S. D., Herman, J. G., & Carducci, M. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0297 · Cited by 121
Benzinger, A., Popowicz, G. M., Joy, J. K., Majumdar, S., Holak, T. A., & Hermeking, H. (2005) · Cell Research · doi:10.1038/sj.cr.7290290 · Cited by 110
Ghahary, A., Marcoux, Y., Karimi‐Busheri, F., Li, Y., Tredget, E. E., Kilani, R. T., Lam, E. C., & Weinfeld, M. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23521.x · Cited by 106
14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s).
Liu, M. Y., Cai, S., Espejo, A. B., Bedford, M. T., & Walker, C. L. (2002) · PubMed · Cited by 98
Loss of 14-3-3σ in Prostate Cancer and Its Precursors
Liang Cheng, C., Pan, C.-X., Zhang, J., Zhang, S., Kinch, M. S., Li, L., Baldridge, L. A., Wade, C. L., Hu, Z., Koch, M. O., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0652 · Cited by 91
Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression
Lodygin, D., Diebold, J., & Hermeking, H. (2004) · Oncogene · doi:10.1038/sj.onc.1208004 · Cited by 89
Mhawech, P., Benz, A., Cerato, C., Gréloz, V., Assaly, M., Desmond, J. C., Koeffler, H. P., Lodygin, D., Hermeking, H., Herrmann, F. R., et al. (2004) · Modern Pathology · doi:10.1038/modpathol.3800240 · Cited by 87
Self-citationLodygin, D., Yazdi, A. S., Sander, C. A., Herzinger, T., & Hermeking, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206854 · Cited by 85
EphB1 Associates with Grb7 and Regulates Cell Migration
Han, D. C., Shen, T., Miao, H., Wang, B., & Guan, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203165200 · Cited by 84
Qi, W., & Martinez, J. D. (2003) · Radiation Research · doi:10.1667/rr3038 · Cited by 81
14-3-3 Family Members Act Coordinately to Regulate Mitotic Progression
Dalal, S. N., Yaffe, M. B., & DeCaprio, J. A. (2004) · Cell Cycle · doi:10.4161/cc.3.5.856 · Cited by 80
The role of epigenetic inactivation of 14-3-3σ in human cancer
Lodygin, D., & Hermeking, H. (2005) · Cell Research · doi:10.1038/sj.cr.7290292 · Cited by 78
Inhibition of Calcium/Calmodulin-dependent Protein Kinase Kinase by Protein 14-3-3
Davare, M. A., Saneyoshi, T., Guire, E. S., Nygaard, S. C., & Soderling, T. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409873200 · Cited by 77
Moreira, J. M. A., Gromov, P., & Celis, J. E. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300134-mcp200 · Cited by 74
Dhar, S., Squire, J. A., Hande, M. P., Wellinger, R. J., & Pandita, T. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7764-7772.2000 · Cited by 68
van Hemert, M. J., Niemantsverdriet, M., Schmidt, T., Backendorf, C., & Spaink, H. P. (2004) · Journal of Cell Science · doi:10.1242/jcs.00990 · Cited by 63
Uchida, S., Kuma, A., Ohtsubo, M., Shimura, M., Hirata, M., Nakagama, H., Matsunaga, T., Ishizaka, Y., & Yamashita, K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01086 · Cited by 62
Nakajima, T., Simooka, H., Weixa, P., SEGAWA, A., Motegi, A., Jian, Z., Masuda, N., Ide, M., Sano, T., Oyama, T., et al. (2003) · Pathology International · doi:10.1046/j.1440-1827.2003.01481.x · Cited by 39
14‐3‐3 regulation of cell spreading and migration requires a functional amphipathic groove
Rodriguez, L. G., & Guan, J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20122 · Cited by 37
Yatabe, Y., Osada, H., Tatematsu, Y., Mitsudomi, T., & Takahashi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1206014 · Cited by 32
Tuberous sclerosis genes regulate cellular 14-3-3 protein levels
Hengstschläger, M., Rosner, M., Fountoulakis, M., & Lübec, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.170 · Cited by 27
Phosphorylation of Grb10 Regulates Its Interaction with 14-3-3
Urschel, S., Bassermann, F. C., Bai, R.-Y., Münch, S., Peschel, C., & Duyster, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501477200 · Cited by 21
Cited by
Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891
“homologous/heterodimers that can bind with two ligands simultaneously.(222) The dimer formation is a necessary regulatory step for its binding to the ligand protein.”
BackgroundBioinformatic and experimental survey of 14-3-3-binding sites
Johnson, C., Crowther, S., Stafford, M. J., Campbell, D. G., Toth, R., & MacKintosh, C. (2010) · Biochemical Journal · doi:10.1042/bj20091834 · Cited by 334
Metadata
- Authors
- MHAWECH, P.
- Venue
- Cell Research
- Published
- 2005-04
- Volume
- 15
- Issue
- 4
- Pages
- 228-236
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W2068880845
- Cited by
- 301
- References
- 72
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.